Phase I pilot trial comparing the pharmacokinetics of controlled-release morphine and oxycodone with sustained-release morphine [MS Contin 30mg] and oxycodone [Oxycontin 20mg]

Trial Profile

Phase I pilot trial comparing the pharmacokinetics of controlled-release morphine and oxycodone with sustained-release morphine [MS Contin 30mg] and oxycodone [Oxycontin 20mg]

Completed
Phase of Trial: Phase I

Latest Information Update: 10 May 2010

At a glance

  • Drugs Morphine; Oxycodone
  • Indications Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 10 May 2010 Subject number added, as reported in a QRxPharma media release.
    • 10 May 2010 Status changed from recruiting to completed, as reported in a QRxPharma media release.
    • 30 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top